Trial Profile
Compare the add-on effects in glycemic control and durability of sitagliptin and alfa-glucosidase inhibitor uncontrolled with metformin monotherapy.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Alpha-glucosidase inhibitors (Primary) ; Sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Nov 2011 New trial record